{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:31:14Z","timestamp":1793399474189,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-026-03004-0","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T05:47:32Z","timestamp":1786340852000},"page":"3243-3254","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Perioperative management of GLP-1 receptor agonists: a structured narrative review with considerations relevant to neurosurgical patients"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8174-9678","authenticated-orcid":false,"given":"Utkan","family":"Top\u00e7u","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferhat","family":"Oto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"3004_CR1","doi-asserted-by":"publisher","unstructured":"Holst JJ (2007) The physiology of glucagon-like peptide 1. Physiol Rev 87(4):1409\u20131439 https:\/\/doi.org\/10.1152\/physrev.00034.2006","DOI":"10.1152\/physrev.00034.2006"},{"issue":"4","key":"3004_CR2","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","volume":"27","author":"DJ Drucker","year":"2018","unstructured":"Drucker DJ (2018) Mechanisms of action and therapeutic application of glucagon-like peptide-1. Cell Metabol 27(4):740\u2013756","journal-title":"Cell Metabol"},{"issue":"11","key":"3004_CR3","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/NEJMoa2032183","volume":"384","author":"JP Wilding","year":"2021","unstructured":"Wilding JP, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I et al (2021) Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med 384(11):989\u20131002","journal-title":"N Engl J Med"},{"issue":"4","key":"3004_CR4","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1603827","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA et al (2016) Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med 375(4):311\u2013322","journal-title":"N Engl J Med"},{"issue":"19","key":"3004_CR5","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Bain SC, Consoli A, Eliaschewitz FG, J\u00f3dar E, Leiter LA et al (2016) Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med 375(19):1834\u20131844","journal-title":"N Engl J Med"},{"issue":"12","key":"3004_CR6","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/S2468-1253(17)30285-6","volume":"2","author":"H Halawi","year":"2017","unstructured":"Halawi H, Khemani D, Eckert D, O\u2019Neill J, Kadouh H, Grothe K et al (2017) Effects of liraglutide on weight, satiation, and gastric functions in obesity: a randomised, placebo-controlled pilot trial. Lancet Gastroenterol Hepatol 2(12):890\u2013899","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"3004_CR7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/dom.13129","volume":"20","author":"MA Nauck","year":"2018","unstructured":"Nauck MA, Meier JJ (2018) Incretin hormones: their role in health and disease. Diabetes Obes Metabolism 20:5\u201321","journal-title":"Diabetes Obes Metabolism"},{"issue":"4","key":"3004_CR8","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.gie.2024.12.019","volume":"101","author":"MU Baig","year":"2025","unstructured":"Baig MU, Piazza A, Lahooti A, Johnson KE, Rangwani S, Gouda Z et al (2025) Glucagon-like peptide-1 receptor agonist use and the risk of residual gastric contents and aspiration in patients undergoing GI endoscopy: a systematic review and a meta-analysis. Gastrointest Endosc 101(4):762\u2013771 e13","journal-title":"Gastrointest Endosc"},{"issue":"8","key":"3004_CR9","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1007\/s12630-023-02440-3","volume":"70","author":"SR Klein","year":"2023","unstructured":"Klein SR, Hobai IA (2023) Semaglutide, delayed gastric emptying, and intraoperative pulmonary aspiration: a case report. Can J Anesthesia\/Journal canadien d\u2019anesth\u00e9sie 70(8):1394\u20131396","journal-title":"Can J Anesthesia\/Journal canadien d\u2019anesth\u00e9sie"},{"key":"3004_CR10","doi-asserted-by":"publisher","first-page":"4090","DOI":"10.1097\/JS9.0000000000002425","volume":"111","author":"JD Wright","year":"2025","unstructured":"Wright JD, Chen L, Xu X, Hur C, Matsuo K, Elkin EB et al (2025) Glucagon-like-peptide-1 (GLP-1) receptor agonist use and the risk of pulmonary aspiration in patients undergoing surgery. Int J Surg (London England) 111:4090\u20134093","journal-title":"Int J Surg (London England)"},{"issue":"1","key":"3004_CR11","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/00000542-199301000-00010","volume":"78","author":"MA Warner","year":"1993","unstructured":"Warner MA, Warner ME, Weber JG (1993) Clinical significance of pulmonary aspiration during the perioperative period. Anesthesiology 78(1):56\u201362","journal-title":"Anesthesiology"},{"issue":"6","key":"3004_CR12","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/EJA.0b013e32835f4d5b","volume":"30","author":"SA Kozek-Langenecker","year":"2013","unstructured":"Kozek-Langenecker SA, Afshari A, Albaladejo P, Santullano CAA, De Robertis E, Filipescu DC et al (2013) Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 30(6):270\u2013382","journal-title":"Eur J Anaesthesiol"},{"issue":"3","key":"3004_CR13","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1097\/00000542-199909000-00022","volume":"91","author":"CC Apfel","year":"1999","unstructured":"Apfel CC, L\u00e4\u00e4r\u00e4 E, Koivuranta M, Greim C-A, Roewer N (1999) A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers. Anesthesiology 91(3):693\u2013700","journal-title":"Anesthesiology"},{"issue":"2","key":"3004_CR14","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1213\/ANE.0000000000004833","volume":"131","author":"TJ Gan","year":"2020","unstructured":"Gan TJ, Belani KG, Bergese S, Chung F, Diemunsch P, Habib AS et al (2020) Fourth consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analgesia 131(2):411\u2013448","journal-title":"Anesth Analgesia"},{"issue":"1","key":"3004_CR15","first-page":"28","volume":"13","author":"S Pierre","year":"2013","unstructured":"Pierre S, Whelan R (2013) Nausea and vomiting after surgery. Contin Educ Anaesth Crit Care Pain 13(1):28\u201332","journal-title":"Contin Educ Anaesth Crit Care Pain"},{"key":"3004_CR16","doi-asserted-by":"publisher","first-page":"414","DOI":"10.4300\/JGME-D-22-00481.1","volume":"14(4)","author":"J Sukhera","year":"2022","unstructured":"Sukhera J (2022) Narrative reviews: flexible, rigorous, and practical. J Grad Med Educ 14(4):414\u2013417 https:\/\/doi.org\/10.4300\/JGME-D-22-00481.1","journal-title":"J Grad Med Educ"},{"issue":"6","key":"3004_CR17","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1053\/j.gastro.2007.03.054","volume":"132","author":"LL Baggio","year":"2007","unstructured":"Baggio LL, Drucker DJ (2007) Biology of incretins: GLP-1 and GIP. Gastroenterology 132(6):2131\u20132157","journal-title":"Gastroenterology"},{"issue":"4","key":"3004_CR18","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/ANA.0000000000000985","volume":"36","author":"LRH Guevara","year":"2024","unstructured":"Guevara LRH, Beam WBB, Pasternak JJ (2024) To the brain and beyond: neurological implications of glucagon-like peptide-1 receptor agonists. J Neurosurg Anesthesiol 36(4):278\u2013282","journal-title":"J Neurosurg Anesthesiol"},{"key":"3004_CR19","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.3389\/fnins.2019.01112","volume":"13","author":"M Grieco","year":"2019","unstructured":"Grieco M, Giorgi A, Gentile MC, d\u2019Erme M, Morano S, Maras B et al (2019) Glucagon-like peptide-1: a focus on neurodegenerative diseases. Front NeuroSci 13:1112","journal-title":"Front NeuroSci"},{"issue":"2","key":"3004_CR20","doi-asserted-by":"publisher","first-page":"785","DOI":"10.2337\/db13-0893","volume":"63","author":"MM Umapathysivam","year":"2014","unstructured":"Umapathysivam MM, Lee MY, Jones KL, Annink CE, Cousins CE, Trahair LG et al (2014) Comparative effects of prolonged and intermittent stimulation of the glucagon-like peptide 1 receptor on gastric emptying and glycemia. Diabetes 63(2):785\u2013790","journal-title":"Diabetes"},{"issue":"12","key":"3004_CR21","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1111\/anae.16454","volume":"79","author":"RS Nersessian","year":"2024","unstructured":"Nersessian RS, da Silva LM, Carvalho MAS, Silveira SQ, Abib AC, Bellicieri FN et al (2024) Relationship between residual gastric content and peri-operative semaglutide use assessed by gastric ultrasound: a prospective observational study. Anaesthesia 79(12):1317\u20131324","journal-title":"Anaesthesia"},{"key":"3004_CR22","doi-asserted-by":"publisher","unstructured":"Elkin J, Rele S, Sumithran P, Hii M, Thuraisingam S, Spelman T et al (2025) Association between glucagon-like peptide\u20101 receptor agonist use and peri\u2010operative pulmonary aspiration: a systematic review and meta\u2010analysis. Anaesthesia 80(7):846\u2013858 https:\/\/doi.org\/10.1111\/anae.16601","DOI":"10.1111\/anae.16601"},{"key":"3004_CR23","doi-asserted-by":"publisher","first-page":"e18743064372550","DOI":"10.2174\/0118743064372550250603061720","volume":"19","author":"PR Elmati","year":"2025","unstructured":"Elmati PR, Jagirdhar GSK, Qasba RK, Perez A, Qasba RK, Bains Y et al (2025) GLP-1 Agonists and the Risk of Pulmonary Aspiration during Elective Upper Endoscopy: A Systematic Review and Meta-analysis. Open Respiratory Med J 19:e18743064372550","journal-title":"Open Respiratory Med J"},{"key":"3004_CR24","doi-asserted-by":"publisher","first-page":"1638981","DOI":"10.3389\/fmed.2025.1638981","volume":"12","author":"D Ukwade","year":"2025","unstructured":"Ukwade D, Hernandez LJ, Modi Z, Raza HS, Siegel M, Nwachukwu D et al (2025) GLP-1 receptor agonist increase retained gastric contents on EGD and same-day colonoscopy reduces this risk. Front Med 12:1638981","journal-title":"Front Med"},{"issue":"2","key":"3004_CR25","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1213\/ANE.0b013e318274fc19","volume":"116","author":"A Perlas","year":"2013","unstructured":"Perlas A, Mitsakakis N, Liu L, Cino M, Haldipur N, Davis L et al (2013) Validation of a mathematical model for ultrasound assessment of gastric volume by gastroscopic examination. Anesth Analgesia 116(2):357\u2013363","journal-title":"Anesth Analgesia"},{"key":"3004_CR26","unstructured":"Joshi GP, Abdelmalak BB, Weigel WA, Soriano SG, Harbell M, Kuo CI et al (2023) American Society of Anesthesiologists consensus-based guidance on preoperative management of patients (adults and children) on glucagon-like peptide-1 (GLP-1) receptor agonists. merican Society of Anesthesiologists, Schaumburg, IL. https:\/\/www.asahq.org. Accessed 7 August 2026"},{"issue":"1","key":"3004_CR27","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s00464-024-11263-2","volume":"39","author":"TL Kindel","year":"2025","unstructured":"Kindel TL, Wang AY, Wadhwa A, Schulman AR, Sharaiha RZ, Kroh M et al (2025) Multi-society clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period. Surg Endosc 39(1):180\u2013183","journal-title":"Surg Endosc"},{"key":"3004_CR28","doi-asserted-by":"publisher","unstructured":"Oprea AD, Ostapenko LJ, Sweitzer B, Selzer A, Irizarry-Alvarado JM, Andrade MDH et al (2025) Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society for Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement. Br J Anaesth 135(1):48\u201378 https:\/\/doi.org\/10.1016\/j.bja.2025.04.001","DOI":"10.1016\/j.bja.2025.04.001"},{"key":"3004_CR29","doi-asserted-by":"publisher","unstructured":"Muranaka MO, Nguyen TH, Wang AT, Cordero J, Yang S-J, Felix J et al (2025) Role of Gastric Point-of-Care Ultrasound in Perioperative Man agement of Semaglutide. Cureus 17(6):e85791 https:\/\/doi.org\/10.7759\/cureus.85791","DOI":"10.7759\/cureus.85791"},{"key":"3004_CR30","doi-asserted-by":"publisher","first-page":"106715","DOI":"10.1016\/j.intimp.2020.106715","volume":"86","author":"J Zhang","year":"2020","unstructured":"Zhang J, Yi T, Cheng S, Zhang S (2020) Glucagon-like peptide-1 receptor agonist Exendin-4 improves neurological outcomes by attenuating TBI-induced inflammatory responses and MAPK activation in rats. Int Immunopharmacol 86:106715","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"3004_CR31","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/S1474-4422(20)30173-3","volume":"19","author":"T Cukierman-Yaffe","year":"2020","unstructured":"Cukierman-Yaffe T, Gerstein HC, Colhoun HM, Diaz R, Garc\u00eda-P\u00e9rez L-E, Lakshmanan M et al (2020) Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial. Lancet Neurol 19(7):582\u2013590","journal-title":"Lancet Neurol"},{"issue":"5","key":"3004_CR32","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.drudis.2016.01.013","volume":"21","author":"D Athauda","year":"2016","unstructured":"Athauda D, Foltynie T (2016) The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson\u2019s disease: mechanisms of action. Drug Discovery Today 21(5):802\u2013818","journal-title":"Drug Discovery Today"},{"issue":"13","key":"3004_CR33","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1056\/NEJMoa2312323","volume":"390","author":"WG Meissner","year":"2024","unstructured":"Meissner WG, Remy P, Giordana C, Malt\u00eate D, Derkinderen P, Hou\u00e9to J-L et al (2024) Trial of lixisenatide in early Parkinson\u2019s disease. N Engl J Med 390(13):1176\u20131185","journal-title":"N Engl J Med"},{"issue":"10","key":"3004_CR34","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1136\/jnnp-2017-317440","volume":"89","author":"SP Mollan","year":"2018","unstructured":"Mollan SP, Davies B, Silver NC, Shaw S, Mallucci CL, Wakerley BR et al (2018) Idiopathic intracranial hypertension: consensus guidelines on management. J Neurol Neurosurg Psychiatry 89(10):1088\u20131100","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"13","key":"3004_CR35","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1212\/WNL.0b013e3182a55f17","volume":"81","author":"DI Friedman","year":"2013","unstructured":"Friedman DI, Liu GT, Digre KB (2013) Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology 81(13):1159\u20131165","journal-title":"Neurology"},{"key":"3004_CR36","doi-asserted-by":"publisher","first-page":"125711","DOI":"10.1016\/j.jns.2025.125711","volume":"480","author":"W Ahmed","year":"2025","unstructured":"Ahmed W, Gandhi OH, Yu N, Brant J, Hwa T, Bagley L et al (2025) Efficacy of glucagon-like peptide-1 receptor agonists in idiopathic intracranial hypertension: A systematic review and meta-analysis. J Neurol Sci 480:125711","journal-title":"J Neurol Sci"},{"key":"3004_CR37","doi-asserted-by":"publisher","unstructured":"Botfield HF, Uldall MS, Westgate CSJ, Mitchell JL, Hagen SM, Gonz\u00e1lez AM et al (2017) A glucagon-like peptide-1 receptor agonist reduces intracranial pressure in a rat model of hydrocephalus.Sci Transl Med. 9(404) : eaan0972 https:\/\/doi.org\/10.1126\/scitranslmed.aan0972","DOI":"10.1126\/scitranslmed.aan0972"},{"key":"3004_CR38","doi-asserted-by":"publisher","first-page":"116119","DOI":"10.1016\/j.amjsurg.2024.116119","volume":"240","author":"JMH Ihnat","year":"2024","unstructured":"Ihnat JMH, de Baun HM, Carrillo G, Dony A, Mukherjee TJ, Ayyala HS (2024) A systematic review of the use of GLP-1 receptor agonists in surgery. Am J Surg 240:116119","journal-title":"Am J Surg"},{"key":"3004_CR39","doi-asserted-by":"publisher","unstructured":"Ononogbu-Uche FC, Toussaint F, Saleh AW, Siddig AHE, Ahmed R, Akl K et al (2025) Do GLP-1 agonists affect perioperative risk in spine surgery? A systematic review and meta-analysis. N Am Spine Soc J 25:100835 https:\/\/doi.org\/10.1016\/j.xnsj.2025.100835","DOI":"10.1016\/j.xnsj.2025.100835"},{"issue":"3","key":"3004_CR40","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/1753-0407.12102","volume":"6","author":"G Mabilleau","year":"2014","unstructured":"Mabilleau G, Mieczkowska A, Chappard D (2014) Use of glucagon-like peptide\u20101 receptor agonists and bone fractures: a meta\u2010analysis of randomized clinical trials. J Diabetes 6(3):260\u2013266","journal-title":"J Diabetes"},{"key":"3004_CR41","doi-asserted-by":"publisher","unstructured":"Vilsb\u00f8ll T, Christensen MB, Junker AE, Knop FK, Gluud LL (2012) Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials. BMJ 344:d7771 https:\/\/doi.org\/10.1136\/bmj.d7771","DOI":"10.1136\/bmj.d7771"},{"key":"3004_CR42","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.clnu.2017.02.013","volume":"36(3)","author":"A Weimann","year":"2017","unstructured":"Weimann A, Braga M, Carli F, Higashiguchi T, H\u00fcbner M, K\u0142\u0119k S et al (2017) ESPEN guideline: Clinical nutrition in surgery. Clin Nutr 36(3):623\u2013650","journal-title":"Clin Nutr"},{"key":"3004_CR43","doi-asserted-by":"publisher","unstructured":"Hathaway JT, Shah MP, Hathaway DB, Zekavat SM, Krasniqi D, Gittinger JW et al (2024) Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide. JAMA Ophthalmol 142(8):732\u2013739 https:\/\/doi.org\/10.1001\/jamaophthalmol.2024.2296","DOI":"10.1001\/jamaophthalmol.2024.2296"},{"key":"3004_CR44","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.arr.2013.07.003","volume":"12","author":"BT Wall","year":"2013","unstructured":"Wall BT, Dirks ML, Loon LJC (2013) Skeletal muscle atrophy during short-term disuse: Implications for age-related sarcopenia. Ageing Res Rev 12:898\u2013906","journal-title":"Ageing Res Rev"},{"key":"3004_CR45","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1111\/dom.14725","volume":"24","author":"JPH Wilding","year":"2022","unstructured":"Wilding JPH, Batterham RL, Davies MJ, Gaal LFV, Kandler K, Konakli K et al (2022) Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes Obes Metab 24:1553\u20131564","journal-title":"Diabetes Obes Metab"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-03004-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-026-03004-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-03004-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:01:28Z","timestamp":1793397688000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-026-03004-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":45,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["3004"],"URL":"https:\/\/doi.org\/10.1007\/s40618-026-03004-0","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"assertion":[{"value":"9 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":1,"name":"Ethics","label":"<b>Competing<\/b> Interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article is based on previously publishedstudies and does not contain any new studies with human participants or animals performed by any of the authors. Ethics approval was therefore not required.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}